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Host-virus interactionThe adenovirus E4 11 k protein, product of E4 ORF3, is required in infection for processes including normal
accumulation of viral late mRNAs. 11 k restructures both the nucleus and cytoplasm of infected cells by
relocalizing speciﬁc host cell target proteins, most strikingly components of nuclear PML oncogenic domains.
It is likely that in many cases relocalization inactivates target proteins to produce 11 k's effects, although the
mechanism and targets for stimulation of late mRNA accumulation is unknown. We have identiﬁed a new set
of proteins relocalized by 11 k: at least ﬁve protein components of cytoplasmic mRNA processing bodies
(p-bodies) are found in 11 k-induced cytoplasmic aggresomes, sites where proteins are inactivated or
destroyed. One of these p-body proteins, RNA helicase Ddx6, binds 11 k, suggesting a mechanism for
relocalization. Because p-bodies are sites for mRNA degradation, their modiﬁcation by 11 k may provide an
explanation for the role of 11 k in viral late mRNA accumulation.l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Adenovirus early proteins function in a variety of processes in infected
cells with the common goal of establishing a host cell environment
favorable for viral replication (Tauber and Dobner, 2001). Viral early
proteins can act both to commandeer host cell machinery for use in viral
replication and to inhibit host cell pathways that might otherwise
interfere with the virus’ life cycle. E4 11 k, product of E4 open reading
frame3 [ORF 3], is one suchprotein. E4 11 k stimulates latemRNAsplicing
and accumulation and viral DNA replication, participates in shutoff of host
protein synthesis, and inhibits DNA damage sensing and prevents viral
genome concatenation (Boyer et al., 1999; Bridge and Ketner, 1989;
Halbert et al., 1985; Huang and Hearing, 1989; Medghalchi et al., 1997;
Ohman et al., 1993; Stracker et al., 2002;Weiden and Ginsberg, 1994). At
least a subset of the activities of E4 11 k are mediated by redistribution of
target host cell proteins in infected cells, which can result in localization
near or away from sites of viral replication. Most dramatically, E4 11 k is
necessary and sufﬁcient to redistribute components of nuclear structures
containing the promyelocytic leukemia protein (PML), known as PML
oncogenic domains or Nuclear Domain 10 (PODs/ND10), from punctatefoci into elongated tracks that eventually surround viral replication
centers (Carvalho et al., 1995; Doucas et al., 1996). PODs/ND10 have been
implicated in diverse cellular processes including innate antiviral re-
sponses, andadenovirusmutants that fail to relocalizePOD/ND10proteins
are sensitive to both interferon-induced and interferon-independent
inhibition of replication (Ullman and Hearing, 2008; Ullman et al., 2007)
and to growth inhibition mediated by the Mre11-Rad50-Nbs1 (MRN)
complex (Ullman et al., 2007; Weitzman and Ornelles, 2005). E4 11 k is
selective in its rearrangement of proteins associated with PODs/ND10.
PML, Sp100, Daxx, SUMO-1, and TIF1α are relocalized into tracks by E4
11 k, but BLM and TopBP1 are not (Doucas et al., 1996; Stracker et al.,
2002, 2005;Ullman et al., 2007; Yondola andHearing, 2007). The basis for
this speciﬁcity is not known.
Among its known targets, the activity of E4 11 k on the Mre11-
Rad50-Nbs1 (MRN) DNA damage sensing complex is unique. While
early in infection MRN is reorganized into characteristic track-like
structures as are POD/ND10 components, E4 11 k ultimately targets
MRN to cytoplasmic aggresomes (Araujo et al., 2005). Aggresomes are
microtubule-dependent cytoplasmic inclusion bodies located adjacent
to the nucleus, frequently in an indentation of the nuclear envelope,
which colocalize with centrosome markers including γ−tubulin and
are often described as surrounded by a vimentin cage (Kopito, 2000).
Aggresomes are believed to contain aggregates of misfolded proteins
(Garcia-Mata et al., 2002) and are enriched in components of the
162 A.E. Greer et al. / Virology 417 (2011) 161–168ubiquitin-proteasome pathway, suggesting that they function as sites
for rapid degradation of unwanted proteins. Aggresomes are rare in
normal cells but prominent in cells that have been stressed by factors
that include viral infection, heat shock, and chemical treatments
(Garcia-Mata et al., 2002; Kopito, 2000; Song et al., 2008; Wileman,
2007). In adenovirus-infected cells, expression either of E4 11 k or
another viral early protein, E1b 55 k, can individually induce aggresome
formation (Araujo et al., 2005; Liu et al., 2005; Stracker et al., 2002). Both
E4 11 k and E1b 55 k relocate MRN to aggresomes, and E1b 55 k also
relocalizes p53 (Zantema et al., 1985). Both of these proteins have
antiviral activity: MRN inhibits adenovirus growth by activation of the
DNA damage response and is required for the viral genome concate-
nation seen in E4 mutant infections, and p53, which is induced by E1a
during adenovirus infection, is potently pro-apoptotic. Relocalization of
at least MRN to E1b 55 k aggresomes interferes with its function and
accelerates proteasomal degradation, (Carson et al., 2009; Liu et al.,
2005) and it is likely that aggresomal p53, without access to its sites of
action in the nucleus, is also nonfunctional. Thus, aggresome induction
and host cell protein relocalization to aggresomes are among the
mechanisms exploited by adenoviruses to abrogate inherent antiviral
defenses and optimize the host cell environment for viral growth.
Here, we show that several proteins that are components of
cytoplasmic RNA processing bodies (p-bodies) are relocalized to
aggresomes induced by E4 11 k expression. Most also appear in
aggresomes induced by chemical stress. However, one of the p-body
proteins relocalized to E4 11 k aggresomes, Ddx6, appears speciﬁcally in
E4 11 k-induced aggresomes and is absent from aggresomes induced byFig. 1. Lsm1 colocalizes with E4 11 k in aggresomes. A. Mock-infected HeLa cells were imm
under ultraviolet illumination. P-bodies, discrete cytoplasmic foci that contain Lsm1, are visib
36 h after infection with Ad5 at a multiplicity of infection of 3000 particles per cell. E4 11 k
defective adenovirus vector carrying an inﬂuenza hemagglutinin (HA) epitope-tagged E4 11
aggresomal marker γ− tubulin (red). The juxtanuclear E4 11 k/Lsm1 foci (arrows) co-stain f
the micrograph; of those, nine contained E4 11 k-positive foci all of which costained for Lschemical stress. Ddx6 coimmunoprecipitates with E4 11 k, indicating a
physical association between the two proteins, suggesting amechanism
for E4 11 k-induced relocalization. P-bodies are sites of mRNA
degradation (Eulalio et al., 2007). E4 11 k stimulates viral late gene
expression by promoting the accumulation of viral late mRNAs which
are rapidly degraded in E4 mutant infections. The activity of E4 11 k on
p-body components therefore may reveal a mechanism for stimulation
of late gene expression by E4 11 k. The mechanisms of aggresome
formation and virus-induced relocalization to aggresomes are not well
understood. The interaction described here between E4 11 k and Ddx6
therefore also provides a tool that will be useful in investigating these
processes.
Results
E4 11 k targets several p-body components to aggresomes
In the course of a study to determine whether E4 proteins affected
the integrity of mRNA processing bodies (p-bodies; Fig. 1A), we noticed
that plasmid-driven expression of Ad5 E4 11 k (product of E4 ORF 3) in
HeLa cells relocalized a portion of the p-body protein Lsm1 to E4 11 k-
containing foci located near the nucleus (not shown). Similar foci
containing both Lsm1 and E4 11 kwere also found in HeLa cells infected
by Ad5 (Fig. 1B) and in cells infected with a defective adenovirus vector
expressing anHAepitope-taggedAd5E411 k (E1::11 k; Fig. 1C). E411 k
induces the formation of aggresomes, microtubule-dependent cyto-
plasmic inclusion bodies characterized by juxtanuclear location andunostained for Lsm1 (green) and stained for DNA with DAPI (blue) and photographed
le in each cell. B. HeLa cells were stained for Lsm1 (green), E4 11 k (red) and DNA (blue)
and Lsm1 colocalze in foci that lie near the nucleus (arrows). C. Cells infected with a
k gene in place of E1 (E1::11 k) were stained for Lsm1 (green), E4 11 k (HA, blue) and
or γ− tubulin, indicating that they are aggresomes. The cell shown here was one of 20 in
m1 and γ-tubulin.
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et al., 2005; Johnston et al., 1998). The E4 11 k-Lsm1 foci that we
observed resembled aggresomes. Therefore,we infectedHeLa cellswith
theHA-tagged E411 k vector and co-stained the infected cells for Lsm-1,
HA-tagged E4 11 k, and γ−tubulin as an aggresome marker. Approx-
imately half of the infected cells contained perinuclear foci that stained
for E4 11 k. All of these foci also contained Lsm1 and all co-stained for
γ−tubulin, conﬁrming that they are bona ﬁde aggresomes (Fig. 1C). The
distribution of Lsm1within aggresomeswas frequently irregular (Figs. 1
B and C). This was noted previously for members of the MRN complex,
whichare also relocalized to aggresomes byE411 k (Araujo et al., 2005),
and similar uneven distributions are seen for the other p-body
components relocated to aggresomes by E4 11 k (below). Irregularity
may reﬂect the history of the aggresomes, which are thought to arise by
coalescence of smaller cytoplasmic aggregates, or internal functional
differentiation.
P-bodies are dynamic accumulations of a large number of proteins
involved inmRNAmetabolism. Todeterminewhether E4 11 k candirect
p-body components other than Lsm1 to aggresomes, we evaluated
localization of additional p-body components including RNA helicase
Ddx6, scaffolding protein Ge-1, RNAi endonuclease Ago2, and 5'-3'
exonuclease Xrn1 in cells containing E4 11 k expressed from Ad5Fig. 2. Other p-body proteins colocalize with E4 11 k aggresomes. A - D. HeLa cells infect
(green). Xrn1 (red,), Argonaute 2 (red) and E4 11 k [HA] (green in A, C, and D or red in B). Nu
in juxtanuclear foci that co-stain with E4 11 k (arrows). E. P-body proteins are not foun
aggresomes from most uninfected cells.(Ddx6) or from the defective adenovirus vector (all four proteins). Each
of these proteins was found inmost E4 11 k aggresomes (Fig. 2; see the
legend for Table 1, below). Thus, multiple p-body components are
relocalized to aggresomes induced by E4 11 k expression.
P-bodies persist in the cytoplasm of most cells that contain E4 11 k
aggresomes (Fig. 1B). We investigated whether the numbers of p-
bodies are reduced as p-body proteins are relocalized to aggresomes
by counting p-bodies in E4 11 k vector-infected cells co-stained for E4
11 k and for Ddx6, Lsm1, or Ge-1. Ddx6, Lsm1, or Ge-1 foci were
counted in 100 cells, which were then scored for the presence of an
aggresome by E4 11 k ﬂuorescence (Table 1). Cells with aggresomes
contained signiﬁcantly fewer p-bodies that stain for either Ddx6 or
Lsm-1 than did cells without aggresomes, consistent with the
hypothesis that relocalization of Lsm-1 and Ddx6 to E4 11 k
aggresomes depletes p-bodies of those proteins. In contrast, in neither
of two experiments was a signiﬁcant reduction in Ge-1 foci observed
in aggresome-containing cells. This may indicate that an insufﬁcient
fraction of the Ge-1 present in p-bodies is relocated to affect the
number of Ge-1 foci detected by immunoﬂuorescence, or that Ge-1
appearing in E4 11 k aggresomes does not originate in p-bodies.
The E4 34 k/E1b 55 k E3 ubiquitin ligase shares some targets with
E4 11 k, such as Mre11. To determine whether p-body proteins wereed with the E1::11 k vector were immunostained for p-body proteins Ddx6 (red), Ge-1
clei were stained with DAPI (blue). In infected cells, each of the p-body proteins is found
d in comparable juxtanuclear foci in uninfected cells, consistent with the absence of
Table 1
P-bodies in cells with and without aggresomes. Cells infected with the Ad5 E4 11 k
vector were stained for E4 11 k and for Ddx6 and Lsm1, or for E4 11 k and for Ge-1. The
number of Ddx6, Lsm1, or Ge-1 p-bodies visible in each of 100 well-deﬁned cells was
determined in each experiment. Cells were then scored for aggresomes by examining
E4 11 k staining. Signiﬁcance was determined using Student's T test (2-tailed, equal
variance). * Ddx6 and Lsm1 p-bodies were counted in the same experiment in cells
triply stained for Ddx6, Lsm1, and E4 11 k. In this experiment, Lsm1 and Ddx6 were
each present in 58 of 60 E4 11 k aggresomes examined, while two aggresomes were
negative for both proteins. Ge-1 was present in 61 of 67 aggresomes examined.
p-body
stain
Aggresome
status
p-bodies per cell
(average)
p Number
of cells
Ddx6* - 18.5 0.014 40
+ 13.9 60
Lsm-1* - 9.4 0.0016 40
+ 6.3 60
Ge-1 - 12.9 0.68 33
+ 13.6 67
164 A.E. Greer et al. / Virology 417 (2011) 161–168targets for virus-mediated degradation, particularly late in infection,
we examined steady-state levels of Ddx6, Lsm-1 and a number of
other p-body proteins in infected cells. None of the proteins
examined, including Lsm1 and Ddx6, were noticeably degraded
under conditions where DNA Ligase IV was completely ablated
(Suplementary Fig. 1 and data not shown) and the proteins examined
therefore are not targets of the E4 34 k/E1b 55 k E3 ubiquitin ligase.
E4 11 k aggresome formation is speciﬁc to Ad5
Proteins reorganized by E4 11 k include PML, the members of the
MRN complex and transcription factor TIF1α. While TIF α reorganiza-
tion is conserved across adenovirus serotypes, ability to reorganizeMRN
is restricted to Ad5 E4 11 k, indicating that E4 11 k-induced reorgani-
zation of TIF1α and MRN are separable functions (Stracker et al., 2005;
Yondola and Hearing, 2007). To determine whether ability to form
aggresomes and/or relocalize p-body components is conserved, we
examined E4 11 k, Lsm1, and Ddx6 distribution in HeLa cells infected
with vectors expressing HA-tagged E4 11 k from Ad3, Ad4, Ad9 and
Ad12, which together with Ad5 represent ﬁve of the six subgroups of
human adenoviruses. Expression of E4 11 k proteins from these vectors
was similar, as assessed by immunoblotting for the HA tag (not shown)
and E4 11 k from all serotypes formed the early nuclear tracks
characteristic of E4 11 k (Doucas et al., 1996; Fig. 3A). Ad5 E4 11 k
progressed to form aggresomes as deﬁned by location and co-staining
with γ−tubulin (Fig. 3A). Ad9 E4 11 k formed rare perinuclear
accumulations (Figs. 3A and B) and both Ad4 and Ad9 E4 11 k formed
elongated cytoplasmic structures in about 25% of infected cells (Figs. 3C
and D). However, none of the structures formed by either Ad4 or Ad9 E4
11 k co-stained forγ−tubulin (Figs. 3C andD). In cells stained for E4 11 k
and for Lsm1 or Ddx6, 80-95% of the cytoplasmic Ad4 and Ad9 E4 11 kFig. 3. Serotype speciﬁcity and effects of E4 11 k mutations on aggresome
formation. HeLa cells were infected with vectors expressing HA-tagged E4 11 k from
Ad3, Ad4, Ad5, Ad9 or Ad12. A, B. Cells were immunostained for E4 11 k (HA, green), for
the aggresomal marker γ− tubulin (red), and for DNA (blue). Ad5 E4 11 k and
γ− tubulin co-localize (solid arrows). Juxtanuclear foci containing Ad9 E4 11 k do not
contain γ− tubulin (open arrows), indicating that they are not aggresomes. Lsm1 is
also absent from these foci (data not shown). C, D. Top rows: HeLa cells were infected
with vectors expressing HA tagged-E4 11 k from Ad4 or Ad9 and were immunostained
for Lsm1 (green) and E4 11 k [HA] (red). DNA is stained with DAPI (blue). E4 11 k from
both Ad4 and Ad9 can be found in elongated cytoplasmic accumulations that also
contain Lsm1 but that are distinguishable from Ad5 aggresomes by morphology and
location (open arrows). Bottom rows: Cytoplasmic structures containing Ad 4 or Ad9
E4 11 k do not co-stain for γ− tubulin. E. Wild type Ad5 E4 11 k forms aggresomes
(arrows, ﬁrst panel). The substitution mutant proteins N82A, and L103A show diffuse
cytoplasmic and nuclear localization but do not appear in aggresomes. D105A/L106A
forms early track-like nuclear structures, but not aggresomes. Stained for E4 11 k (red
or green); ﬁrst and fourth panels also stained with DAPI.
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respectively) or Ddx6 (n=10 and 5). We conclude that classical
aggresome formation by E4 11 k is Ad5 speciﬁc, but that other serotypes
relocalize at least Lsm1andDdx6 todiscrete cytoplasmic structureswhich
may have functions analogous to those of aggresomes in Ad5 infection.
A series of Ad5 E4 11 kmutants have been evaluated for their ability
to reorganize the previously identiﬁed E4 11 k targets PML, MRN and
TIF1α (Evans and Hearing, 2005; Yondola and Hearing, 2007). Single
amino acid substitution mutants N82A and L103A fail to form track-like
structures and do not reorganize PML, MRN or TIF1α. The double point
mutantD105A/L106A can relocalize PML to early track-like structures, but
cannot reorganize MRN or TIF1α We examined aggresome formation
by these mutants by infecting HeLa cells with adenovirus E1-
replacement vectors expressing HA-tagged versions of N82A, L103A,
and D105A/L106A and co-stained the cells for HA (E4 11 k) and Ddx6 or
Lsm1. None of the mutants formed aggresomes and none displayed co-
localization with Ddx6 or Lsm1 (Fig. 3E and not shown).
P-body proteins in aggresomes induced by chemical stress
At least twomechanisms might account for the relocalization of p-
body components to E4 11 k-induced aggresomes. E4 11 k might
interact with one or more p-body components and actively mediate
their movement to aggresomes. Alternatively, the presence of
aggresomes, once induced by E4 11 k, could promote relocalization
of p-body components without further participation of E4 11 k itself.
To differentiate these hypotheses, we examined aggresomes formed
without involvement of E4 11 k for the presence of p-body
components. Treatment with cadmium chloride (CdCl2) induces
aggresome formation in a variety of cells (Song et al., 2008), and we
evaluated the localization of Lsm1, Ge-1, and Ddx6 in HeLa cellsFig. 4. P-body proteins in cadmium-induced aggresomes.HeLa cells were treated with CdC
Ddx6 (red, C) and the aggresomal marker γ− tubulin (red, A and B or green, C). DNA was sta
but Ddx6 is not. Arrows indicate aggresomes in each panel.treated with CdCl2 (Fig. 4). Aggresomes were identiﬁed in cells after
6 h of treatment with CdCl2 by staining for γ− tubulin and by
juxtanuclear location. Lsm1 and Ge-1 were detected, respectively, in
21 out of 23 and 7 out of 9 of γ− tubulin–positive CdCl2 aggresomes
examined (Figs. 4A and B), indicating that interactions with E4 11 k
are not necessary for relocalization of these proteins to aggresomes. In
contrast, Ddx6 was detected in none of the 12 cadmium-induced
aggresomes examined (Fig. 4C). This suggests the possibility that
Ddx6 is speciﬁcally relocated to aggresomes via an interaction with E4
11 k.
E4 11 k and Ddx6 physically interact
The speciﬁcity of association between Ddx6 and E4 11 k aggresomes
suggests that E4 11 k participates actively in the relocalization of Ddx6,
perhaps through a physical interaction. To test the hypothesis that E4
11 k and Ddx6 physically associate, we immunoprecipitated Ddx6 from
mock-infected HeLa cells and from HeLa cells infected with vectors
expressing HA-tagged wild type E4 11 k, HA-tagged E4 11 k mutant
N82A, which neither reorganizes nuclear E4 11 k targets nor forms
aggresomes (Evans and Hearing, 2005; Yondola and Hearing, 2007 and
data not shown), or GFP as a control. Immunoprecipitates were
examined by immunoblotting for HA-tagged E4 11 k and Ddx6 (to
conﬁrm successful immunoprecipitation) (Fig. 5A). E4 11 k was readily
detected in Ddx6 precipitates from cells expressing the wild type
protein, but not in those from cells expressing the N82A mutant despite
substantial overexpression of the mutant protein. No HA-reactive
material was detected in immunoprecipitates from mock-infected
cells or cells infected with the GFP vector. Thus, E4 11 k associates
either directly or indirectly with Ddx6, and this association is abrogated
by a mutation that interferes with normal E4 11 k functions includingl2 for 6 hours. Treated cells were immunostained for Lsm1 (green, A), Ge-1 (green, B) or
ined with DAPI (blue). Lsm1 and Ge-1 are relocalized to cadmium-induced aggresomes,
Fig. 5. E4 11 k and Ddx6 co-immunoprecipitate. HeLa cells were infected with vectors
expressing HA-tagged wild type or mutant N82A E4 11 k, GFP or lacZ. 16 hours post-
infection, cells were lysed in RIPA buffer and lysates were incubated with anti-Ddx6 (A)
or anti-HA [E4 11 k] (B) antibodies coupled to magnetic beads. Immune complexes
were recovered, fractionated on 10-20% Tricine gels, and analyzed by immunoblotting
for Ddx6 or E4 11 k (HA). 1% of the input material blotted for Ddx6 and E4 11 k is shown
in the top rows of each panel and immunoprecipitates are shown in the bottom rows.
Ddx6 immunoprecipitates speciﬁcally contain wild type HA-E4 11 k, but not themutant
N82A. E4 11 k immunoprecipitates from cells infected with a vector expressing wild
type E4 11 k are enriched in Ddx6 compared to those from cells infectedwith an N82A or
lacZ vector control, or from mock-infected cells.
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immunoprecipitates made with anti-HA antibody, which precipitates
HA-taggedE4 11 k,were examined for the presence of Ddx6 (Fig. 5B). In
those experiments, Ddx6 was found at low levels in all precipitates,
including those made from mock- and lacZ vector-infected cells.
However, the signal was reproducibly more intense in wild type- but
not in N82A-infected cells, consistent with the conclusion that Ddx6 and
E4 11 k interact, and that the interaction is disrupted by the N82A
mutation. The E4 11 k immunoprecipates were also examined for the
presence of Lsm1 but none was detected (data not shown), suggesting
that Lsm1 and E4 11 k do not interact physically.
Discussion
E4 11 k and E4 34 k, the products of E4 ORFs 3 and 6, respectively,
each satisfy the requirement for E4 in processes in infected cells that
include viral late mRNA accumulation and inhibition of DNA damage
response and repair pathways (Bridge and Ketner, 1989; Huang and
Hearing, 1989; Stracker et al., 2002). Despite their functional redun-
dancy, the E4 34 k and E4 11 k proteins act by distinct mechanisms. E4
34 k, with the 55 kDa product of E1b, constitutes the substrate-binding
component of an E3 ubiquitin ligase that targets speciﬁc host cell
proteins for proteasomal destruction, while E4 11 k acts by inducing
relocalization of host cell proteins which, in at least one case, results in
inactivation of its target (Carson et al., 2009; Liu et al., 2005; Querido
et al., 2001). Both proteins thus are capable of interfering with the
functions of host cell proteins, presumably inhibiting processes or
pathways that otherwise would be inhibitory to viral growth. Some
targets of E4 34 k and E4 11 k are held in common, such as MRN, while
others such as DNA ligase IV, are not. In the latter cases, it is likely that
the redundancy in the function of the E4 proteins reﬂects their
inhibition of common pathways via effects on different speciﬁc targets.
The work reported here identiﬁes a set of new proteins relocalized
by E4 11 k. The new targets are mRNA processing body (p-body)
components Lsm1, Ge-1, Ago2, Xrn1 and Ddx6.Whilemost previously
identiﬁed E4 11 k targets are nuclear proteins and are relocalized to
structures within the nucleus, the targets identiﬁed here are
principally cytoplasmic, and E4 11 k expression results in relocaliza-
tion to cytoplasmic aggresomes. At least Lsm1 and Ge-1 are also
present in aggresomes induced by cadmium treatment. This indicatesthat relocalization of these p-body proteins to aggresomes does not
require a speciﬁc interaction with E4 11 k. In contrast, Ddx6 is absent
from cadmium-induced aggresomes. We have also shown that Ddx6
co-immunoprecipitates with wild type E4 11 k from extracts of
vector-infected cells, but not with non-functional mutant E4 11 k. This
strongly suggests a mechanism for relocalization of Ddx6 to aggre-
somes mediated by a physical interaction with E4 11 k.
Aggresome formation occurs by coalescence of smaller aggregates of
misfolded proteins directed to the centrosome by microtubules. P-
bodies are also anchored to microtubules, display spatially conﬁned
motion dependent onmicrotubule motion, and stationary p-bodies can
be identiﬁed at the centrosome (Aizer et al., 2008). Aggresome
formation accompanies gross microtubule rearrangement within cells,
and it may not be surprising that as a result, p-bodies tethered to
microtubules would move to aggresomes along with other material
destined for aggresomal localization. This is consistent with our
observation that most of the p-body proteins we have evaluated appear
to be relocalized to aggresomes induced by E4 11 k or cadmium. It is
perplexinghowever, if p-bodies are trafﬁcked enmasse to aggresomes as
a result of microtubule rearrangements, why Ddx6 is found only in E4
11 k aggresomes and not in aggresomes induced by cadmium. Since
Ddx6 remains associated with surviving p-bodies in cells that harbor
aggresomes, its absence from cadmium-induced aggresomes must be a
consequenceof the structure ormechanismof formationof aggresomes,
rather than the result of dissociation of Ddx6 from p-bodies prior to
aggresome formation. For example, protein-protein interactions that
occur in aggresomes may interfere with interactions that bind Ddx6 to
other components of cytoplasmic p-bodies. Whatever explains the
failure of Ddx6 to appear in aggresomes induced by other agents, the
existence of a mechanism to speciﬁcally incorporate Ddx6 into
aggresomes in infected cells reinforces the hypothesis that aggresomal
localization and likely inactivation of Ddx6 is critical for viral growth.
Aggresomes are believed to arise when, under conditions of stress,
misfolded proteins accumulate to levels beyond the capacity of
constitutive protein quality-control mechanisms to eliminate them,
and it is generally assumed that aggresomes are sites for emergency
sequestration and inactivation of potentially harmful proteins. Adeno-
viruses exploit aggresomes for a similar purpose: MRN, when
incorporated into aggresomes is inactive as assessed by its inability to
form radiation-induced foci on chromosomal DNA or initiate DNA
damage signaling (Carson et al., 2009; Liu et al., 2005), and aggresome
formation thus contributes to the inactivation of MRN required for
efﬁcient viral growth. It is likely that aggresomal relocalizationofp-body
proteins inhibits their activity similarly. While classical aggresome
formation is observed only for Ad5 E4 11 k, the E4 11 k proteins of at
least two other serotypes, Ad4 and Ad9, formed γ-tubulin-negative
cytoplasmic structures that contained Lsm-1 and Ddx6. These may be
functionally analogous to the aggresomes induced by Ad5 E4 11 k and
inactivate similar pathways.
E4 11 k and the E4 34 k/E1b 55 k complex redundantly promote
efﬁcient adenovirus late gene expression (Bridge and Ketner, 1989;
Huang and Hearing, 1989). In their absence, late messages are
transcribed at a normal rate, but do not accumulate and must therefore
be degraded (Sandler and Ketner, 1989). P-bodies are sites of mRNA
decay and contain proteins that participate in 5’ to 3’ mRNA decay,
ARE-mediated degradation (AMD),mRNA surveillance by the nonsense
mediated decay (NMD)pathway, andmRNA translational repression by
the microRNA (miRNA)-mediated silencing pathway (Anderson and
Kedersha, 2009; Eulalio et al., 2007). While the implications of the
relocalization of Ddx6 and other p-body components on adenovirus
growth are not yet certain, the latemRNAphenotype of E4mutants and
the connection of p-bodies to mRNA degradation suggests the
possibility that effects on p-body function contributes to the effects of
E4 11 k on viral late mRNA accumulation.
Ddx6 is a member of the SF2 DEAD-box RNA helicase family
(Weston and Sommerville, 2006) and a deﬁning component of p-
167A.E. Greer et al. / Virology 417 (2011) 161–168bodies in cells ranging from yeast to humans. The helicase activity of
Ddx6 is essential for p-body formation (Minshall et al., 2009), and
Ddx6 has been implicated in aspects of mRNA metabolism that
include transcription, splicing, translation, decapping enhancement
and degradation (Cordin et al., 2006; Linder, 2006; Rocak and Linder,
2004). Ddx6 has been shown to physically interact with several other
p-body components including decapping enhancers Pat1, Lsm1-7,
EDC3, Dcp1, Dcp2 and Ge-1 (Coller and Parker, 2005; Coller et al.,
2001; Decker et al., 2007). Ddx6 also binds Ago1 and Ago2, and is
essential for miRNA-mediated gene silencing (Chu and Rana, 2006).
Disruption of any of these associations might contribute to E4 11 k-
stimulated late mRNA accumulation. The C-terminal domain of Ddx6
is required for interactions with protein partners and localization to
p-bodies (Minshall et al., 2009) and the conserved RecA homology
domain required for RNA binding is also located in the C-terminus
(Cordin et al., 2006). It will be of interest to determine whether the
interaction of E4 11 k and Ddx6 is mediated by the C-terminus of
Ddx6, and whether it is mutually exclusive with interactions with
cellular protein partners.
P-bodies that contain Ddx6 persist in reduced numbers in cells
expressing amounts of E4 11 k sufﬁcient to promote late gene
expression. This indicates that quantitative removal of Ddx6 from p-
bodies cannot be essential for E4 11 k function. Modest reductions in
Ddx6 content of p-bodies or in the number of p-bodies may sufﬁce to
accomplish the required functions of E4 11 k. Alternatively, perhaps a
critical population of Ddx6 either in p-bodies or elsewhere in cells is
relocated to aggresomes and inactivated and the Ddx6 that remains in
p-bodies is not relevant to E4 11 k action. It is also possible that despite
retention of some Ddx6, the p-bodies visible in cells containing E4 11 k
aggresomes are inactive due to E4 11 k function. Finally, although
without obvious precedent, relocation of Ddx6 to aggresomes may
confer some activity upon Ddx6 that is required for viral growth, a
hypothesis untroubled by residual p-body-associated Ddx6.
The implications of the interaction of adenovirus E4 11 k with
Ddx6 and other p-body components is not yet clear. We suggest that
relocalization of p-body proteins, and Ddx6 in particular, interferes
with mRNA decay functions that occur in p-bodies and that that
interference is reﬂected in viral mRNA stabilization by E4 11 k.
Experiments intended to test that hypothesis should provide insight
into an important unresolved issue in adenovirus biology - the
mechanism of E4 stimulation of late gene expression - and may also
clarify our view of p-body function in normal human cells.
Materials and methods
Cell culture
HeLa cells were propagated in Dulbecco modiﬁed Eagle's medium
(11965092, Invitrogen) supplemented with 10% FBS, penicillin and
streptomycin.
Viruses and infections
E1-replacement vectors expressing hemagglutinin (HA)-tagged
wild-type E4 11 k proteins of Ad5, Ad3, Ad4, Ad9 andAd12 andmutants
of Ad5 E4 11 k (N82A, L103A, D105A/L106A) have been described (Evans
and Hearing, 2003, 2005). These recombinants carry deletions of E4
ORFs 1–3, and thus produce E4 11 k only from the transgene located in
E1. Virus particles were puriﬁed by cesium chloride density gradient
centrifugation and were stored frozen in phosphate buffered saline
containing 5% sucrose, 0.5 mM CaCl2, 0.9 mM magnesium acetate.
Particle concentrations were determined from A260 (Challberg and
Ketner, 1981; Mittereder et al., 1996). All infections were performed at
an MOI of 3000 particles/cell. Virus was adsorbed in 10-20% normal
media volume for 2 hours and then replaced with fresh media.Antisera
Antibodies used for immunoﬂuorescence experiments were pur-
chased from the following companies and used at the indicated
dilutions: HA (16B12, Covance), 1:1000; Lsm-1 (GW22100F, Sigma)
1:500; Ddx6 (A300-461A, Bethyl Laboratories) 1:500; Ge-1 [p70 S6
kinase (Stoecklin et al., 2006)] (sc-8416, Santa Cruz) 1:500; Ago2
(ab32381, Abcam) 1:50; Xrn1 (A300-443A, Bethyl Laboratories) 1:50;
γ−tubulin (T3559, Sigma) 1:500; γ−tubulin (T6557, Sigma) 1:2000;
E4 11 k (rabbit polyclonal antiserum raised to a carboxy-terminal
peptide (Boyer et al., 1999)) 1:1000. Alexa Fluor-conjugated secondary
antibodies were purchased from Invitrogen and used at a dilution of
1:200.
HA and Ddx6 antibodies were used for immunoblots at dilutions of
1:1000. Secondary antibodies for immunoblotting experiments were
purchased from GE Healthcare.
Immunoprecipitations and immunoblotting
Beads were prepared by covalently coupling 7 mg anti-HA
(Covance) or anti-Ddx6 (Bethyl Laboratories) per 1 mg of Dynabeads
(Invitrogen) according to the manufacturer's protocol. Antibody
bound-Dynabeads were then blocked in 5% BSA for 30 minutes at
room temperature with rotation. Infected HeLa cells (2.5×107 cells
per 14 cm dish) were harvested 16 hours post-infection in 1 mL
radioimmunoprecipitation assay buffer (RIPA; 50 mM Tris, pH 8.0;
150 mM NaCl; 1.0% NP-40; 0.5% deoxycholic acid; 0.1% sodium
dodecyl sulfate [SDS]) supplemented with a protease inhibitor
cocktail (Sigma, P8340). Lysates were clariﬁed by centrifugation at
13000×g for 10 minutes at 4 °C. 2.5 mg total protein was incubated
with 2 mg of pre-blocked antibody bound-Dynabeads per reaction in
the presence of 1% BSA for 2 hours at 4 °C with rotation. Beads were
washed three times with 0.5 mL RIPA, and bound proteins were
eluted by incubation with 50 mL elution buffer [EB] (provided with
the Dynabead kit) for 5 minutes with rotation.
Whole cell extracts and immunoprecipitation eluates were
prepared in Tricine Sample Buffer (BioRad) boiled 5 minutes and
separated on Novex 10-20% Tricine gels (Invitrogen). Proteins were
electrophoretically transferred to nitrocellulose membranes and
immunoblotted as described (Baker et al., 2007).
Immunoﬂuorescence Microscopy
Cells were seeded on glass coverslips and infected or treated as
indicated. Cells were ﬁxed for 30 minutes in a solution of 2%
formaldehyde in phosphate buffered saline [PBS], washed in PBS,
and permeabilized in ice-cold acetone for 3 minutes. Primary and
secondary antibodies were diluted in 2% BSA; 0.02% NaN3 in PBS. Cells
were incubated with primary antibodies for 1 hour, washed three
times in PBS and incubated with secondary antibodies for 30 min.
Cells were washed three times more in PBS and mounted on slides
with mounting solution (100 mM Tris, pH 8.8; 50% glycerol; 2.5%
DABCO; and in some cases 0.2 mg/mL DAPI). All manipulations were
carried out at room temperature, and secondary antibody incubation
and mounting were performed in the dark. Slides were viewed and
images were acquired on a Zeiss 510 Meta confocal microscope using
LSM Image software, or on Nikon E800 or 90i microscopes.
Cadmium Treatment
Cadmium chloride (C-2544, Sigma) was dissolved in distilled
water. Tissue culture media was supplemented with cadmium
chloride at a ﬁnal concentration of 20 mM. Cells were incubated for
6 hours under normal tissue culture conditions, and then prepared for
immunoﬂuorescence as described above.
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